STOCK TITAN
  1. Home
  2. Sec-filings
  3. DLB
  4. [Form 4] Dolby Laboratories, Inc. Insider Trading Activity

DLB insider: CEO option exercise and matched share sales

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Dolby Laboratories (DLB) reported insider activity by President & CEO and Director Kevin Yeaman. On 10/14/2025, he exercised an employee stock option for 25,000 Class A shares at $45.5 per share (code M), then sold 11,214 shares at a weighted average price of $68.5057 and 13,786 shares at a weighted average price of $69.173 (both code S), all held indirectly by a family trust. Following the reported transactions, 114,725 shares were beneficially owned indirectly by the trust. Holdings also include 127,735 RSUs that are subject to vesting.

Positive

  • None.

Negative

  • None.
Insider YEAMAN KEVIN J
Role President and CEO
Sold 25,000 shs ($1.72M)
Type Security Shares Price Value
Exercise Employee Stock Option (Right to Buy) 25,000 $0.00 --
Exercise Class A Common Stock 25,000 $45.50 $1.14M
Sale Class A Common Stock 11,214 $68.5057 $768K
Sale Class A Common Stock 13,786 $69.173 $954K
holding Class A Common Stock -- -- --
holding Class A Common Stock -- -- --
Holdings After Transaction: Employee Stock Option (Right to Buy) — 35,615 shares (Indirect, By a trust); Class A Common Stock — 139,725 shares (Indirect, By a trust); Class A Common Stock — 127,735 shares (Direct)
Footnotes (1)
  1. By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 The shares were sold in multiple transactions at prices ranging from $67.83 to $68.81, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. The shares were sold in multiple transactions at prices ranging from $68.89 to $69.35, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Shares held following the reported transactions include 127,735 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. This option was granted for a total of 194,399 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
YEAMAN KEVIN J
(Last) (First) (Middle)
C/O DOLBY LABORATORIES, INC.
1275 MARKET STREET
(Street)
SAN FRANCISCO CA 94103
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Dolby Laboratories, Inc. [ DLB ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President and CEO
3. Date of Earliest Transaction (Month/Day/Year)
10/14/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 10/14/2025 M 25,000 A $45.5 139,725 I By a trust(1)
Class A Common Stock 10/14/2025 S 11,214 D $68.5057(2) 128,511 I By a trust(1)
Class A Common Stock 10/14/2025 S 13,786 D $69.173(3) 114,725 I By a trust(1)
Class A Common Stock 127,735(4) D
Class A Common Stock 2.5592 I By a son
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (Right to Buy) $45.5 10/14/2025 M 25,000 (5) 12/15/2026 Class A Common Stock 25,000 $0 35,615 I By a trust(1)
Explanation of Responses:
1. By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009
2. The shares were sold in multiple transactions at prices ranging from $67.83 to $68.81, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
3. The shares were sold in multiple transactions at prices ranging from $68.89 to $69.35, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
4. Shares held following the reported transactions include 127,735 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
5. This option was granted for a total of 194,399 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date.
/s/ Daniel Rodriguez as Attorney-in-Fact for Kevin Yeaman 10/16/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did DLB’s CEO transact on 10/14/2025?

He exercised an option for 25,000 shares at $45.5 and sold 11,214 and 13,786 shares at weighted average prices of $68.5057 and $69.173.

How many DLB shares does the trust hold after the transactions?

Following the transactions, 114,725 shares were beneficially owned indirectly by the family trust.

What were the sale price ranges disclosed for DLB shares?

Sales occurred in multiple transactions with ranges of $67.83–$68.81 and $68.89–$69.35; weighted averages reported.

What was the exercise price of the DLB stock option?

The option was exercised at $45.5 per share for 25,000 underlying Class A shares.

Does the CEO have additional equity awards at DLB?

Holdings include 127,735 shares underlying restricted stock units that are subject to forfeiture until they vest.

In what capacity does Kevin Yeaman serve at DLB?

He is a Director and serves as President and CEO.